MD Anderson at Cooper is a clinical research site located in Camden, New Jersey, United States 08103.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
MD Anderson at Cooper has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer.
Sponsors: Iovance Biotherapeutics, Inc., Imunon.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MD Anderson at Cooper has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MD Anderson at Cooper has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer.
MD Anderson at Cooper has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.